Last reviewed · How we verify
A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy Participants
The main purpose of this study is to evaluate the effect of itraconazole and carbamazepine on LY3537982 when administered as multiple doses by conducting the blood tests to measure how much LY3537982 is in the bloodstream and how the body handles and eliminates LY3537982 in adult healthy participants. The study will also evaluate the safety and tolerability of LY3537982. The study is conducted in two parts. Participants will stay in the research center during the study, which will last about 11 and 15 days for part 1 and part 2, respectively, not including screening.
Details
| Lead sponsor | Eli Lilly and Company |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 30 |
| Start date | Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy
Interventions
- LY3537982
- Itraconazole
- Carbamazepine
Countries
United States